TEOSYAL references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
Teosyal RHA 3
TEOSYAL RHA 3 is a sterile, transparent, non-pyrogenic, viscoelastic hyaluronic acid filler of non-animal origin from Teoxane SA in Geneva, with a mean molecular weight above 1 million Dalton. It is cross-linked with BDDE and contains 0,3% by mass of lidocaine hydrochloride.
At 23 mg/mL it is indicated for the correction of deep facial wrinkles and deep skin creases, for adding volume in the midface and for remodelling the lower face. Each box contains two pre-filled syringes of 1,2 mL, each with two sterile 27G 1/2 inch needles and two traceability labels.
Key Benefits of Teosyal RHA 3
- Corrects deep facial wrinkles and deep skin creases
- Adds volume in the midface and remodels the lower face
- Also indicated for the perioral region, including the lips
- Hyaluronic acid at 23 mg/mL with a degree of cross-linking below 5%
- Mean molecular weight above 1 million Dalton, of non-animal origin, residual BDDE below 1 ppm
- Contains lidocaine hydrochloride 0,3% by mass to reduce the sensation of pain
- Two pre-filled 1,2 mL syringes per box, each with two sterile 27G 1/2 inch needles
- Estimated duration of 12 to 18 months
Indications and Professional Use
Main indications
- Correction of any deep facial wrinkles and deep skin creases
- Adding volume in the midface
- Remodelling of the lower face
Professional use
TEOSYAL RHA 3 is only to be administered by appropriately trained healthcare professionals who are qualified or accredited in accordance with national law, and is not for retail sale or self-administration. It is injected slowly at variable depths depending on the area treated: into the dermis, subcutaneously, onto the supraperiosteum, or into the subdermis or the submucosa of the red lips. Where a cannula is used, an entry point is made in the skin with a sharp needle of appropriate size. It must not be injected into the epidermis, into or close to a blood vessel, close to a nerve, or at depths other than those described. Depending on the correction required, one or more treatment sessions or a touch-up may be needed.
Treatment areas
- Midface: nasolabial folds, cheeks, nasojugal groove
- Lower face: chin, jawline
- Perioral region: lips including the philtrum, marionette lines, oral commissures
Patient profile
For adults assessed as suitable by the treating practitioner, typically those with deep creases or midface volume loss rather than fine surface lines. It must not be used in patients with cutaneous disorders, inflammation or infection at or near the treatment site, since injection procedures can lead to reactivation of latent or subclinical herpes viral infection. Because of the lidocaine content it must not be used in patients with known hypersensitivity to lidocaine or to amide local anaesthetics, or in patients with hepatocellular insufficiency or undergoing related treatment.
How Teosyal RHA 3 Works
TEOSYAL RHA 3 works through hyaluronic acid at 23 mg/mL with a degree of cross-linking below 5%, delivered in a larger 1,2 mL syringe through a wider 27G needle than RHA 1 and RHA 2. Hyaluronic acid binds water and restores volume where tissue has been lost, which is what allows this grade to fill a deep crease and rebuild midface volume.
The low cross-linking is what distinguishes the RHA line from firmer fillers at the same concentration: the gel adapts to tissue that moves, which matters in the nasolabial region and the lower face.
Why Order From Allpara
Allpara offers genuine, verified TEOSYAL products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.
Frequently Asked Questions
How does TEOSYAL RHA 3 differ from RHA 2 and RHA 4?
All three carry 23 mg/mL hyaluronic acid with cross-linking below 5%. RHA 2 is for facial wrinkles and creases across four regions, in a 1 ml syringe with 30G needles. RHA 3 is for deep wrinkles and midface volume, in a 1,2 ml syringe with 27G needles. RHA 4 is for facial contour remodelling in thick skin areas, also 1,2 ml with 27G, and lasts 15 to 18 months rather than 12 to 18.
How long does TEOSYAL RHA 3 last?
Teoxane states an estimated in vivo lifetime of 12 to 18 months. Duration depends on skin type, the severity of the wrinkle treated, the injection area, the volume injected, and the patient's physiology and lifestyle.
Where can clinics buy TEOSYAL RHA 3?
ALLPARA supplies TEOSYAL RHA 3 to licensed practitioners, clinics and distributors on a B2B account. Wholesale terms, stock position and batch expiry are released to registered professional buyers.
More from Teoxane
TEOXANE references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
TEOXANE Products
View all 18Clinic alternatives
Pick up where you left off
Teosyal RHA 3
TEOSYAL RHA 3 is a sterile, transparent, non-pyrogenic, viscoelastic hyaluronic acid filler of non-animal origin from Teoxane SA in Geneva, with a mean molecular weight above 1 million Dalton. It is cross-linked with BDDE and contains 0,3% by mass of lidocaine hydrochloride.
At 23 mg/mL it is indicated for the correction of deep facial wrinkles and deep skin creases, for adding volume in the midface and for remodelling the lower face. Each box contains two pre-filled syringes of 1,2 mL, each with two sterile 27G 1/2 inch needles and two traceability labels.
Key Benefits of Teosyal RHA 3
- Corrects deep facial wrinkles and deep skin creases
- Adds volume in the midface and remodels the lower face
- Also indicated for the perioral region, including the lips
- Hyaluronic acid at 23 mg/mL with a degree of cross-linking below 5%
- Mean molecular weight above 1 million Dalton, of non-animal origin, residual BDDE below 1 ppm
- Contains lidocaine hydrochloride 0,3% by mass to reduce the sensation of pain
- Two pre-filled 1,2 mL syringes per box, each with two sterile 27G 1/2 inch needles
- Estimated duration of 12 to 18 months
Indications and Professional Use
Main indications
- Correction of any deep facial wrinkles and deep skin creases
- Adding volume in the midface
- Remodelling of the lower face
Professional use
TEOSYAL RHA 3 is only to be administered by appropriately trained healthcare professionals who are qualified or accredited in accordance with national law, and is not for retail sale or self-administration. It is injected slowly at variable depths depending on the area treated: into the dermis, subcutaneously, onto the supraperiosteum, or into the subdermis or the submucosa of the red lips. Where a cannula is used, an entry point is made in the skin with a sharp needle of appropriate size. It must not be injected into the epidermis, into or close to a blood vessel, close to a nerve, or at depths other than those described. Depending on the correction required, one or more treatment sessions or a touch-up may be needed.
Treatment areas
- Midface: nasolabial folds, cheeks, nasojugal groove
- Lower face: chin, jawline
- Perioral region: lips including the philtrum, marionette lines, oral commissures
Patient profile
For adults assessed as suitable by the treating practitioner, typically those with deep creases or midface volume loss rather than fine surface lines. It must not be used in patients with cutaneous disorders, inflammation or infection at or near the treatment site, since injection procedures can lead to reactivation of latent or subclinical herpes viral infection. Because of the lidocaine content it must not be used in patients with known hypersensitivity to lidocaine or to amide local anaesthetics, or in patients with hepatocellular insufficiency or undergoing related treatment.
How Teosyal RHA 3 Works
TEOSYAL RHA 3 works through hyaluronic acid at 23 mg/mL with a degree of cross-linking below 5%, delivered in a larger 1,2 mL syringe through a wider 27G needle than RHA 1 and RHA 2. Hyaluronic acid binds water and restores volume where tissue has been lost, which is what allows this grade to fill a deep crease and rebuild midface volume.
The low cross-linking is what distinguishes the RHA line from firmer fillers at the same concentration: the gel adapts to tissue that moves, which matters in the nasolabial region and the lower face.
Why Order From Allpara
Allpara offers genuine, verified TEOSYAL products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.
Frequently Asked Questions
How does TEOSYAL RHA 3 differ from RHA 2 and RHA 4?
All three carry 23 mg/mL hyaluronic acid with cross-linking below 5%. RHA 2 is for facial wrinkles and creases across four regions, in a 1 ml syringe with 30G needles. RHA 3 is for deep wrinkles and midface volume, in a 1,2 ml syringe with 27G needles. RHA 4 is for facial contour remodelling in thick skin areas, also 1,2 ml with 27G, and lasts 15 to 18 months rather than 12 to 18.
How long does TEOSYAL RHA 3 last?
Teoxane states an estimated in vivo lifetime of 12 to 18 months. Duration depends on skin type, the severity of the wrinkle treated, the injection area, the volume injected, and the patient's physiology and lifestyle.
Where can clinics buy TEOSYAL RHA 3?
ALLPARA supplies TEOSYAL RHA 3 to licensed practitioners, clinics and distributors on a B2B account. Wholesale terms, stock position and batch expiry are released to registered professional buyers.